Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
Phathom Pharmaceuticals, Inc. (PHAT)
Sector: Healthcare; Industry: Biotechnology

Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. The company was incorporated in 2018 and is based in Buffalo Grove, Illinois.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2023-01-20 Curran Terrie President and Chief Executive Sell 5,821 $8.20 $47,729 Yes
2023-01-12 Parikh Asit Director Buy 5,000 $7.00 $35,000 No
2022-11-21 Henderson Molly CFO and CBO Sell 2,159 $9.60 $20,726 No
2022-11-21 Curran Terrie President and Chief Executive Sell 1,526 $9.60 $14,650 No
2022-05-16 Nabulsi Azmi Chief Operating Officer Buy 20,000 $8.16 $163,288 No
2022-05-13 Curran Terrie President and Chief Executive Buy 20,500 $7.41 $151,835 No
2022-05-12 Parikh Asit Director Buy 12,500 $8.00 $100,000 No
2022-03-14 TAKEDA PHARMACEUTICAL CO LTD 10%-Owner Sell 18 $19.00 $342 Yes
2019-10-29 COLA MICHAEL F Director Buy 9,798 $19.00 $186,162 No
2021-10-08 Socks David A Director Sell 18,000 $32.58 $586,395 No
2021-09-22 Socks David A Director Sell 18,000 $32.63 $587,351 No
2021-08-16 Socks David A Director Sell 18,000 $31.25 $562,538 No
2021-07-07 TAKEDA PHARMACEUTICAL CO LTD 10%-Owner Sell 2,609 $35.05 $91,445 No
2021-07-02 TAKEDA PHARMACEUTICAL CO LTD 10%-Owner Sell 8,326 $35.16 $292,727 No
2021-06-29 Socks David A Director Sell 40,000 $34.05 $1,361,941 No
2021-06-28 TAKEDA PHARMACEUTICAL CO LTD 10%-Owner Sell 24,501 $35.49 $869,427 No
2021-06-24 TAKEDA PHARMACEUTICAL CO LTD 10%-Owner Sell 11,048 $35.14 $388,199 No
2021-06-22 TAKEDA PHARMACEUTICAL CO LTD 10%-Owner Sell 9,394 $35.31 $331,671 No
2021-06-18 TAKEDA PHARMACEUTICAL CO LTD 10%-Owner Sell 8,703 $35.11 $305,571 No
2021-06-14 TAKEDA PHARMACEUTICAL CO LTD 10%-Owner Sell 2,826 $35.06 $99,080 No
2021-06-10 TAKEDA PHARMACEUTICAL CO LTD 10%-Owner Sell 3,293 $35.19 $115,883 No
2021-06-08 TAKEDA PHARMACEUTICAL CO LTD 10%-Owner Sell 2,364 $35.05 $82,853 No
2021-06-02 TAKEDA PHARMACEUTICAL CO LTD 10%-Owner Sell 4,300 $35.18 $151,274 No
2021-06-01 TAKEDA PHARMACEUTICAL CO LTD 10%-Owner Sell 20,116 $35.96 $723,434 No
2021-05-27 TAKEDA PHARMACEUTICAL CO LTD 10%-Owner Sell 20,811 $36.84 $766,700 No
2021-05-25 TAKEDA PHARMACEUTICAL CO LTD 10%-Owner Sell 21,541 $35.93 $773,889 No
2021-05-21 TAKEDA PHARMACEUTICAL CO LTD 10%-Owner Sell 18,746 $35.50 $665,439 No
2021-05-20 Socks David A Director Sell 40,000 $32.64 $1,305,506 No
2021-05-14 TAKEDA PHARMACEUTICAL CO LTD 10%-Owner Sell 100 $35.00 $3,500 No
2021-05-13 TAKEDA PHARMACEUTICAL CO LTD 10%-Owner Sell 11,876 $35.44 $420,892 No

Insider Smart

Altimmune, Inc. (ALT) - Venrock Healthcare Capital Partners III, L.P., 10%-owner of ALT bought 1.3M shares in late May then added another 1.5M shares in June with an averaged ~$8 per share. 10 days after the accumulation, ALT price jumped to $10.

Insider Smart

Carvana Co (CVNA) - One of the best timed insider buying in the crash is from GARCIA ERNEST C. II 10%-owner of CVNA. Bought at 45 and now with a 100%+ profit.